chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Herpes Zoster; This initial spontaneous information was received from a lawyer regarding a case in litigation and refers to a patient of unknown age and gender.  On or about 21-NOV-2011, the patient was inoculated with zoster vaccine live (ZOSTAVAX) by a healthcare provider for the long-term prevention of shingles and/or zoster-related conditions. Subsequent to patient's zoster vaccine live (ZOSTAVAX) inoculation, the patient was treated by a healthcare provider for herpes zoster. As a direct and proximate result of patient's use of the zoster vaccine live (ZOSTAVAX) vaccine, patient has and will continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and will continue to suffer such losses, and damages in the future.  The outcome of the event was unknown. The event was considered to be related to zoster vaccine live (ZOSTAVAX).
pt. experiencing heaviness/tingling in the LVE.     pt. denies any  difficulty swallowing and/or other signs/ symptoms.  pt. advised to stay at the vaccination site an additional 15 mins to be monitored.    pt. declined.   pt. advised to f/u with her pcp/ call 911 if anything changes/ worsens.  pt. verbalized understanding.
Ringing in ears; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ew0171) via an unspecified route of administration in the left arm on 17May2021 at 17:30 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Patient did not receive any other medication within two weeks of vaccination. The patient had no known allergies to food, medication or other products. On 02Jun2021, about two weeks after vaccination, the patient experienced ringing in ears. The patient did not receive any treatment for the event. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event ringing in ears was not recovered at the time of this report.
Presented with irretractable N/V; incidental + covid test; CXR: a couple small patchy densities; Tx: supportive- Vit C, Vit D3, Singulair, Zinc, lovenox ; remained on room air during stay
7 year old female patient received dose 1 of the pediatric formulation (orange cap) of Pfizer-BioNTech Covid-19 vaccine. Approximately 5 minutes after patient was immunized, she reported feeling light headed. The nurse immunizer helped the patient sit down in her dad's lap. She became pale and lethargic though was speaking and breathing regularly. The healthcare provider on-site (PA-C) was alerted of the situation, and immediately responded to the patient. The patient then had a brief loss of consciousness for about 3 seconds. She was immediately laid down during that time and awoke when aroused. Pulse was 90bpm with a regular rhythm and SpO2 94 on RA. With deep and controlled breathing, SpO2 rose to 98 on RA within 1 minute. EMS was called as a precaution. The patient denied trouble breathing or swallowing, and there were no signs of external rashes or inflammation. Parents denied transport to medical facility or emergency room. Paramedic and PA-C agreed that this was a vasovagal syncopal event.
After 5 minutes after the patient received the vaccine, she reported that her throat was swelling. I offered to give her 2 Benadryl by mouth. She took them. A minute or two later, I asked her how she was doing? she said the throat swelling was still there. I offered the EpiPen. She accepted my offer. I gave her the EpiPen. A minute later she said her throat was better.  About 15 minutes later, she said she felt better and wanted to go home. I also offer to call 911 for evaluation. She declined. I let her go home. She said she lived close by and her daughter was with her.
This is a spontaneous report from a contactable other healthcare professional. A female patient of unknown age received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. On 06May2021, the patient experienced lymph node under armpit swelling. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. It was unknown whether any therapeutic measures were taken as a result of the event. The clinical outcome of the event lymph node under armpit swelling was resolving at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. No information regarding the patient's medical history, concurrent conditions and concomitant medications was provided. On 07-FEB-2016, the patient was vaccinated with the dose of improperly exposed (to 20 F for 72 hours) ZOSTAVAX injection, subcutaneously, lot # L000448, expiration date 08-MAR-2016 (dose was not reported). No known adverse effects were reported. Additional information has been requested.
Got second shot in the morning: Last night 11:00pm started having fever 101, chill, bad headache.  Took Tylenol. Today has a little headache, no fever, chills are better. Don't feel well enough to go to work.
On 09/20/21 pt presented vaccination card with only Pfizer recorded.   Discovered in immunization registry that a previous Moderna dose had been given on 05/06/21. Pt had not informed clinic on 8/30/21 that she had had a previous Moderna vaccination . Client was provided a new Vaccination card showing both previous doses on 09/20/21.    No 3rd vaccination given.
The information has been received from a physician concerning an elderly female patient who on 24-AUG-2015 was subcutaneously vaccinated with PNEUMOVAX 23 injection drug as prophylaxis for the first time. There was no concomitant medication reported. On an unspecified date in August 2015, the patient developed vaccination site swelling. On 26-AUG-2015, the patient developed pyrexia and vomiting. On an unspecified date, the patient was hospitalized as she developed pneumonia aspiration due to vomiting. At the time of this report, the outcome of vomiting, pneumonia aspiration, vaccination site swelling and pyrexia were unknown because the patient was still hospitalized. The reporter considered that the vaccination site swelling and pyrexia were related to PNEUMOVAX 23, but vomiting is not related to PNEUMOVAX 23. Vomiting is considered as serious because the patient was hospitalized with pneumonia aspiration due to vomiting. Additional information has been requested.
Given 10mcg dose of Moderna Bivalent instead of recommended 25 mcg dose
Menstrual bleeding at the wrong  time of my cycle a day after getting the shot.  Happened on both the second shot and the booster. First time I had just finished my period the second time my period was due in 2.5 weeks.  I am very regular usually.
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 21-AUG-2015, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 0.5ml, (lot # K012424, expiration date 05-JUN-2016). This specified lot number vaccine was exposed to temperature excursion twice. The total cumulative excursion time of the first time was 24 hours with the lowest recorded temperature of -1 Fahrenheit degree. The total cumulative excursion time of the second time was 48 hours with the lowest recorded temperature of 0 Fahrenheit degree. The storage criteria and the type of excursion for this vaccine was refrigerator (R). No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
Patient has redness and itching  in left arm.  Also said had headache which improved after a couple of days and a pain under the right rib cage which went away.
Patient receive flu vaccine between 11:30-12:30pm 10/12/16 and called the main office at 2:30pm to report shortness of breath and tightness in chest. Was seen by RN at 2:35pm at work site, EMS called and told pt she needed to be seen by an MD. Pt refused ambulance ride but rode with husband to ER. Patient was not given meds (Epi/BENADRYL) by EMS.
i felt muscle ache, head ache and sore arm for the first 48 hours;  48 hours after the vaccine I experienced sharp, stabbing mid/right sided chest pain - it lasted 36-48hours;  that subsided and I have experienced constant chest pressure for a 5-7 days  and now intermittent chest pressure .   I went to the ER 10/17/22  blood work, chest x-ray was normal, EKG showed a  non specific abnormal ekg in the ST.   I had a follow up with the internal medicine on 10/21/22with a repeated ekg and an order for a cardiac stress test.  stress test is scheduled
Received immunizations at approximately 6:50PM, went to waiting room where brother and sister saw her fall to floor hitting her head (?left side) on a wooden playbox. They said she just stared for about 5 seconds then left arm / shoulder was twitching when RN arrived, patient was conscious and in a chair. She was pale, P68 at a FBV minutes, before 7pm, BP was 108/78, P78 standing. She was still dizzy and c/o headache, so ambulance was called. She was observed in ER and discharged home.
This is a spontaneous report received from a contactable consumer or other non-HCP (patient). A patient (no qualifiers provided) received unknown dose number of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, batch/lot# unknown), in left arm, single dose, for COVID-19 immunisation. Medical history scar (unspecified if ongoing); cancer (unspecified if ongoing); and tumor (unspecified if ongoing). The patient's concomitant medications not reported. The patient experienced vaccination site swelling ("it's like a lot of fluid is just pooled-up underneath; it's the size of a golf ball or a tennis ball/it's all around the scar/it's all under my left arm where I had my shot"), with outcome of unknown. No follow-up attempts possible. Information about batch/lot  number cannot be obtained. No further information expected.
At 11:10 am , RN attempted to vaccinate client with 2nd dose Pediatric Pfizer Covid vaccine Lot#FL8094 into the left deltoid.  As the syringe made contact with the client's left deltoid, the client moved her arm and the the Pfizer Covid vaccine  was unable to be pushed in. RN immediately placed the wasted Pediatric Pfizer Covid vaccine Lot#FL8094 into the sharps container. At 11:21 am Client was successfully vaccinated into the right deltoid by another RN with Pediatric Covid Vaccine Lot#FL8094 without incident.
my injection site is still swollen like a softball; my injection site is red hot.; my injection site is red hot.; This case was reported by a consumer via interactive digital media and described the occurrence of injection site swelling in a patient who received Herpes zoster (Shingrix) for prophylaxis.   In April 2022, the patient received the 1st dose of Shingrix. In April 2022, less than a week after receiving Shingrix, the patient experienced injection site swelling, injection site erythema and injection site warmth. On an unknown date, the outcome of the injection site swelling, injection site erythema and injection site warmth were not recovered/not resolved.   It was unknown if the reporter considered the injection site swelling, injection site erythema and injection site warmth to be related to Shingrix.     Additional Information: GSK Receipt Date: 24-APR-2022 Reporter's Comment: The patient self-reported this case via interactive digital media. The patient received dose of Shingrix vaccine on Thursday and his/her injection site was still swollen like a softball and red hot. The patient asked was this normal. Additional supportive information: The follow-up would not possible, as no contact, details were available.
Reports she developed hives and wheezing same day (initially said within 4 hours, then shared it might have been within 7 hours) as her 1st COVID vaccine Pfizer dose. She reports calling her allergist and was recommended to take benadryl 50 mg po. She reports her symptoms improved so she did not go to seek emergency care. She reports numerous food and environmental allergies.
Left deltoid redness, warmth, swelling, and itching that developed the following day.
There was swelling for a few days that went down but suddenly today in the injection area it got worse and is like a golf ball sized lump that?s rock hard and itches really bad
Systemic: Dizziness / Lightheadness-Medium, Systemic: Fainting / Unresponsive-Mild, Systemic: Flushed / Sweating-Mild, Additional Details: patient explained before vaccination that she normally faints after vaccines. shortly after shot patient felt very lightheaded and very breifly fainted though unconfirmed if she was fully unconcious. patient was advised to sit on floor in fetle position and given water where she recovered fully shortly afterwards with no further complications.
Client received Astrazeneca in , while he was working there. He was unable to complete the series. He then received Pfizer as a new series in . Client had no reaction to the first dose of Astrazeneca.
This spontaneous report as received from a consumer refers to her friend, a female patient of unknown age. Information on the patient's pertinent medical history, concurrent conditions and drug reactions/allergies were not reported. On an unknown date the patient was vaccinated with an unspecified HPV vaccine (also reported as miscellaneous because it is referencing adverse effects from an unspecified HPV vaccine, and a MSD product cannot be ruled out). Concomitant medication were not reported. The consumer reported, "The vaccine is a con. So many people have been injured by this vaccine! A friend of mine literally has trouble walking now and she's not even 25 years old. Totally fine before this." (See MARRS# 1610USA009450). The outcome of so many people being injured was not specified. This is one of two reports received from same reporter. Additional information is not expected.
Got really sick; This spontaneous case was reported by an other health care professional and describes the occurrence of ILLNESS (Got really sick) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (Got really sick). At the time of the report, ILLNESS (Got really sick) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.   This case was linked to MOD-2022-568296, MOD-2022-568298, MOD-2021-024069, MOD-2022-571305 (Patient Link).
Patient developed fever, spreading erythema, swelling, one small blister, and induration over right thigh 1 day after receiving immunizations. Admitted for observation, with improvement of erythema, swelling, and induration and resolution of fever after receiving 3 doses of IV clindamycin. Patient was discharged home on PO clindamycin x 7 days for R thigh cellulitis.
The injection site is still red; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (The injection site is still red) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J202A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 15-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (The injection site is still red). At the time of the report, VACCINATION SITE ERYTHEMA (The injection site is still red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  Treatment details are not provided.
Deep muscle aches first at injection site and then all over...got rash in midsection as well...symptoms about 24 hours after shot, feeling better about 9/26.
Tingling in lips and tongue. Scratchiness in neck and facial area (right side). Vitals within normal limits; Benadryl 50 mg PO given.
Arm swelling with pain and couldn't move arm she has used ice and took MOBIC twice daily. She followed with us to check everything was ok. Had Tdap on 4/12/18 in the left arm. By that night she had arm swelling, pain and could not move her arm. Has since put on ice every few hours and took MOBIC twice daily. She feels much better now. She want to make sure there is no other problems. Also has right arm pain that comes and goes. Works in housekeeping. Pain in elbow and forearm and can affect the shoulder at times. Chronic x many years. For her vertigo notes she took medication: difenidol/vontrol.
Rash on both arms starting end Sept ?( per Mom), seen in ER x2 beginning of October and Nov 21st, was prescribed steroids and ZYRTEC, also advised to see a dermatologist as patient still has the rash.
The patient said it's making me so sick I can't barely function; Something for the gut to try and help it/ something to help digest the food; The second shot gave her cramps; Diarrhea; My skin is white; I'm just tired; Had a slight fever; Headache; Body aches said at first it was my breast and around the neck but now is just around the neck; On sept 27th, when she was initially scheduled for the second dose; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (The patient said it's making me so sick I can't barely function), DYSPEPSIA (Something for the gut to try and help it/ something to help digest the food), MUSCLE SPASMS (The second shot gave her cramps), DIARRHOEA (Diarrhea) and SKIN DISCOLOURATION (My skin is white) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020F21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in December 2020.    On 26-Oct-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Oct-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (On sept 27th, when she was initially scheduled for the second dose). On an unknown date, the patient experienced ILLNESS (The patient said it's making me so sick I can't barely function), DYSPEPSIA (Something for the gut to try and help it/ something to help digest the food), MUSCLE SPASMS (The second shot gave her cramps), DIARRHOEA (Diarrhea), SKIN DISCOLOURATION (My skin is white), FATIGUE (I'm just tired), PYREXIA (Had a slight fever), HEADACHE (Headache) and MYALGIA (Body aches said at first it was my breast and around the neck but now is just around the neck). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) at an unspecified dose and frequency. On 26-Oct-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (On sept 27th, when she was initially scheduled for the second dose) had resolved. At the time of the report, ILLNESS (The patient said it's making me so sick I can't barely function), DYSPEPSIA (Something for the gut to try and help it/ something to help digest the food), MUSCLE SPASMS (The second shot gave her cramps), DIARRHOEA (Diarrhea), SKIN DISCOLOURATION (My skin is white), FATIGUE (I'm just tired), PYREXIA (Had a slight fever), HEADACHE (Headache) and MYALGIA (Body aches said at first it was my breast and around the neck but now is just around the neck) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In October 2021, Weight: 21 (Low) Lost 21 pounds.         The patient has been taking unspecified medicines and homeopathic. The patient was taking some gastrointestinal stuff and something to help digest the food. The patient said that on sept 27th, when she was initially scheduled for the second dose, felt like I was having a heart attack   This case was linked to MOD-2021-369263 (Patient Link).
Patient received 1st dose of Moderna vaccine on 2/11/21 then received 2nd dose on 2/25/21 instead of the intended 3/11/21.
Positive COVID PCR test on 7/28/21.  Patient with tactile fever, body aches, chills, cough, nasal congestion, runny nose, fatigue.
COVID-19 Treatment; COVID-19 Treatment; .This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 31-year-old male patient received BNT162b2 (BNT162B2), on 10Oct2021 as dose number unknown, single (Batch/Lot number: unknown) at the age of 30 years for covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing); "Allergies" (unspecified if ongoing); "Depression" (unspecified if ongoing); "Anxiety" (unspecified if ongoing). There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID-19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown results. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Additional information: Anti-viral treatment start date was 12Jun2022 to 17Jun2022.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Resident was given an undiluted vaccine. No adverse reactions, vital signs remained within the residents norm.
administered Menveo but he wanted to receive Bexsero.; This case was reported by a other health professional via call center representative and described the occurrence of wrong vaccine administered in a 20-year-old male patient who received Men ACWY-CRM NVS (Menveo) for prophylaxis.   On 24th October 2021, the patient received Menveo. On 24th October 2021, unknown after receiving Menveo, the patient experienced wrong vaccine administered. On an unknown date, the outcome of the wrong vaccine administered was unknown.  Additional details were provided are as follows: Pharmacy manager reported that a patient was administered Menveo but he wanted to receive Bexsero. which led to wrong vaccine administered. The Vaccine Administration Facility was the same as Primary Reporter. The reporter did not have had details of lot and expiry date of Menveo. The reporter consented to follow-up.